We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+11.44%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$644M
AUM Growth
+$320M
Cap. Flow
+$288M
Cap. Flow %
44.77%
Top 10 Hldgs %
23.99%
Holding
104
New
10
Increased
74
Reduced
Closed
2

Top Sells

Rank Stock Value
1
DWSN
DAWSON GEOPHYSICAL CO
DWSN
+$2.21M
2
TRAW icon
Traws Pharma
TRAW
+$264K
3
VVUS
Vivus Inc
VVUS
+$253K

Sector Composition

Rank Sector Weight
1 Healthcare 23.69%
2 Consumer Discretionary 13.71%
3 Technology 11.28%
4 Industrials 11%
5 Materials 7.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSII
76
DELISTED
Cardiovascular Systems, Inc.
CSII
$1.68M 0.26%
52,700
+29,900
+131% +$988K
TLPH icon
77
Talphera
TLPH
$70.1M
$1.67M 0.26%
6,970
+4,320
+163% +$1.02M
CEMP
78
DELISTED
Cempra, Inc.
CEMP
$1.65M 0.26%
143,200
+78,900
+123% +$981K
FMI
79
DELISTED
Foundation Medicine, Inc.
FMI
$1.59M 0.25%
49,200
+37,700
+328% +$1.23M
MGNX icon
80
MacroGenics
MGNX
$240M
$1.56M 0.24%
56,200
+37,200
+196% +$1.31M
FEIC
81
DELISTED
FEI COMPANY
FEIC
$1.52M 0.24%
14,800
+8,800
+147% +$865K
LITS
82
Lite Strategy Inc
LITS
$33.6M
$1.51M 0.24%
6,805
+3,700
+119% +$667K
BLUE
83
DELISTED
bluebird bio
BLUE
$1.48M 0.23%
5,018
+3,034
+153% +$919K
SHPG
84
DELISTED
Shire pic
SHPG
$1.46M 0.23%
9,800
+3,400
+53% +$524K
ATHN
85
DELISTED
Athenahealth, Inc.
ATHN
$1.43M 0.22%
8,900
+4,900
+123% +$806K
NBIX icon
86
Neurocrine Biosciences
NBIX
$18.7B
$1.41M 0.22%
87,300
+48,800
+127% +$835K
INSM icon
87
Insmed
INSM
$22B
$1.37M 0.21%
72,000
+39,100
+119% +$743K
XOMA
88
DELISTED
Xoma
XOMA
$1.34M 0.21%
12,860
+6,780
+112% +$984K
AMBI
89
DELISTED
Ambit Biosciences Corp
AMBI
$1.2M 0.19%
131,100
+57,000
+77% +$605K
CTRA
90
DELISTED
Coterra Energy
CTRA
$1.19M 0.19%
35,200
MDSO
91
DELISTED
Medidata Solutions, Inc.
MDSO
$1.03M 0.16%
18,900
+4,900
+35% +$299K
PCRX icon
92
Pacira BioSciences
PCRX
$1.06B
$931K 0.14%
13,300
ATHX
93
DELISTED
Athersys, Inc. Common Stock
ATHX
$860K 0.13%
10,612
+3,528
+50% +$326K
RGEN icon
94
Repligen
RGEN
$7.03B
$691K 0.11%
53,700
MDAS
95
DELISTED
MEDASSETS INC COM STK (DE)
MDAS
$655K 0.1%
26,500
TFX icon
96
Teleflex
TFX
$5.86B
$622K 0.1%
5,800
VIRX
97
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$607K 0.09%
437
CERS icon
98
Cerus
CERS
$579M
$469K 0.07%
97,800
RMD icon
99
ResMed
RMD
$30.3B
$442K 0.07%
9,900
RPTP
100
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$404K 0.06%
40,400

Similar funds

Eventide Asset Management's Q1 2014 Portfolio in Review

As of Q1 2014, Eventide Asset Management held 104 positions worth $644M, up 98% from $325M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management deployed $288M of net new capital in Q1 2014, opening 10 new positions and adding to 74 existing holdings. Its largest new stake was Terex: 303,500 shares worth $13.4M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the most notable exit was DAWSON GEOPHYSICAL CO, an estimated $2.21M sold.

  • Eventide Asset Management's largest Q1 2014 buy was Terex: 303,500 shares worth $13.4M.
  • Eventide Asset Management added most to Interactive Intelligence Group, inc. in Q1 2014, an estimated $11.5M increase.
  • Eventide Asset Management fully exited DAWSON GEOPHYSICAL CO in Q1 2014, selling an estimated $2.21M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $644M portfolio in Q1 2014.
  • Eventide Asset Management opened 10 new positions and closed 2 in Q1 2014.
  • Eventide Asset Management's portfolio value rose 98% quarter-over-quarter to $644M.

Based on Eventide Asset Management's 13F filing for Q1 2014, filed 13 May 2014.